236 related articles for article (PubMed ID: 33972037)
1. What we have learned from the COVID-19 pandemic: Time to think outside the box, maybe far outside.
Lambert WC; Alhatem A; Lambert MW; Schwartz RA
Clin Dermatol; 2021; 39(1):107-117. PubMed ID: 33972037
[TBL] [Abstract][Full Text] [Related]
2. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
Kouzy R; Abi Jaoude J; Garcia Garcia CJ; El Alam MB; Taniguchi CM; Ludmir EB
JAMA Netw Open; 2020 Jul; 3(7):e2015100. PubMed ID: 32658285
[TBL] [Abstract][Full Text] [Related]
3. Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region.
Eleni M; Evangelia M; Eleftheria K; Vasilios V; Vana S; Vissaria S; Evangelos B; Ioannis K
Pathog Glob Health; 2021 Jun; 115(4):243-249. PubMed ID: 33645468
[TBL] [Abstract][Full Text] [Related]
4. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic.
Watanabe JH; Kwon J; Nan B; Abeles SR; Jia S; Mehta SR
JAMA Netw Open; 2021 May; 4(5):e2110775. PubMed ID: 34019090
[TBL] [Abstract][Full Text] [Related]
5. Repurposing antimalarials and other drugs for COVID-19.
Schlagenhauf P; Grobusch MP; Maier JD; Gautret P
Travel Med Infect Dis; 2020; 34():101658. PubMed ID: 32247925
[No Abstract] [Full Text] [Related]
6. Pharmacotherapy in COVID-19; A narrative review for emergency providers.
Mehta N; Mazer-Amirshahi M; Alkindi N; Pourmand A
Am J Emerg Med; 2020 Jul; 38(7):1488-1493. PubMed ID: 32336586
[TBL] [Abstract][Full Text] [Related]
7. Audio Interview: Studying Potential Covid-19 Therapies.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 May; 382(19):e72. PubMed ID: 32379957
[No Abstract] [Full Text] [Related]
8. A Case of Breakthrough COVID-19 during Hydroxychloroquine Maintenance.
Ahn BY; Kang CK; Seo JD; Choe PG; Song SH; Park WB; Park SW; Kim NJ; Oh MD
J Korean Med Sci; 2020 Jun; 35(24):e231. PubMed ID: 32567262
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review.
Sanders JM; Monogue ML; Jodlowski TZ; Cutrell JB
JAMA; 2020 May; 323(18):1824-1836. PubMed ID: 32282022
[TBL] [Abstract][Full Text] [Related]
10. Possible treatment and strategies for COVID-19: review and assessment.
Trivedi N; Verma A; Kumar D
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12593-12608. PubMed ID: 33336780
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 Drugs Chloroquine and Hydroxychloroquine, but Not Azithromycin and Remdesivir, Block hERG Potassium Channels.
Szendrey M; Guo J; Li W; Yang T; Zhang S
J Pharmacol Exp Ther; 2021 May; 377(2):265-272. PubMed ID: 33674391
[TBL] [Abstract][Full Text] [Related]
12. Streptococcus pneumoniae coinfection in hospitalised patients with COVID-19.
Anton-Vazquez V; Clivillé R
Eur J Clin Microbiol Infect Dis; 2021 Jun; 40(6):1353-1355. PubMed ID: 33462723
[No Abstract] [Full Text] [Related]
13. COVID-19 treatment combinations and associations with mortality in a large multi-site healthcare system.
Coppock D; Baram M; Chang AM; Henwood P; Kubey A; Summer R; Zurlo J; Li M; Hess B
PLoS One; 2021; 16(6):e0252591. PubMed ID: 34115801
[TBL] [Abstract][Full Text] [Related]
14. Hepatic transplant during SARS-CoV-2 (COVID-19) pandemic. A literature review.
Pérez-González B; Thomas-Lora FC; Hoyo I; Flores-García NC; Rodríguez-Aguilar EF; Páez-Zayas VM; Márquez-Guillén E; Visag-Castillo V; García-Juárez I; Contreras AG
Cir Cir; 2021; 89(2):269-274. PubMed ID: 33784290
[TBL] [Abstract][Full Text] [Related]
15. Audio Interview: Covid-19 in South Africa and a New SARS-CoV-2 Variant.
Rubin EJ; Baden LR; Abdool Karim SS; Morrissey S
N Engl J Med; 2021 Jan; 384(2):e14. PubMed ID: 33497556
[No Abstract] [Full Text] [Related]
16. Uncertain effects of hydroxychloroquine and azithromycin on SARS-Cov-2 viral load.
Nguyen TV
Int J Antimicrob Agents; 2021 Jan; 57(1):106169. PubMed ID: 33408026
[No Abstract] [Full Text] [Related]
17. Immune responses and therapeutic challenges in paediatric patients with new-onset acute myeloid leukaemia and concomitant COVID-19.
Patel PA; Lapp SA; Grubbs G; Edara VV; Rostad CA; Stokes CL; Pauly MG; Anderson EJ; Piantadosi A; Suthar MS; Khurana S; Sabnis HS
Br J Haematol; 2021 Aug; 194(3):549-553. PubMed ID: 34096051
[No Abstract] [Full Text] [Related]
18. A Perspective on Emerging Therapeutic Interventions for COVID-19.
Torequl Islam M; Nasiruddin M; Khan IN; Mishra SK; Kudrat-E-Zahan M; Alam Riaz T; Ali ES; Rahman MS; Mubarak MS; Martorell M; Cho WC; Calina D; Docea AO; Sharifi-Rad J
Front Public Health; 2020; 8():281. PubMed ID: 32733837
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological treatment of COVID-19: Narrative review of the Working Group in Infectious Diseases and Sepsis (GTEIS) and the Working Groups in Transfusions and Blood Products (GTTH).
Díaz E; Amézaga Menéndez R; Vidal Cortés P; Escapa MG; Suberviola B; Serrano Lázaro A; Marcos Neira P; Quintana Díaz M; Catalán González M
Med Intensiva (Engl Ed); 2021 Mar; 45(2):104-121. PubMed ID: 32854988
[TBL] [Abstract][Full Text] [Related]
20. Psychopharmacology of COVID-19.
Bilbul M; Paparone P; Kim AM; Mutalik S; Ernst CL
Psychosomatics; 2020; 61(5):411-427. PubMed ID: 32425246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
